These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 12010861)

  • 1. Suppression of mammary tumorigenesis in transgenic mice by the RXR-selective retinoid, LGD1069.
    Wu K; Kim HT; Rodriquez JL; Hilsenbeck SG; Mohsin SK; Xu XC; Lamph WW; Kuhn JG; Green JE; Brown PH
    Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):467-74. PubMed ID: 12010861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The retinoid X receptor-selective retinoid, LGD1069, prevents the development of estrogen receptor-negative mammary tumors in transgenic mice.
    Wu K; Zhang Y; Xu XC; Hill J; Celestino J; Kim HT; Mohsin SK; Hilsenbeck SG; Lamph WW; Bissonette R; Brown PH
    Cancer Res; 2002 Nov; 62(22):6376-80. PubMed ID: 12438218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of biomarkers modulated by the rexinoid LGD1069 (bexarotene) in human breast cells using oligonucleotide arrays.
    Kim HT; Kong G; Denardo D; Li Y; Uray I; Pal S; Mohsin S; Hilsenbeck SG; Bissonnette R; Lamph WW; Johnson K; Brown PH
    Cancer Res; 2006 Dec; 66(24):12009-18. PubMed ID: 17178900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond tamoxifen: the retinoid X receptor-selective ligand LGD1069 (TARGRETIN) causes complete regression of mammary carcinoma.
    Bischoff ED; Gottardis MM; Moon TE; Heyman RA; Lamph WW
    Cancer Res; 1998 Feb; 58(3):479-84. PubMed ID: 9458093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoprevention of mammary carcinoma by LGD1069 (Targretin): an RXR-selective ligand.
    Gottardis MM; Bischoff ED; Shirley MA; Wagoner MA; Lamph WW; Heyman RA
    Cancer Res; 1996 Dec; 56(24):5566-70. PubMed ID: 8971154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor-selective retinoids inhibit the growth of normal and malignant breast cells by inducing G1 cell cycle blockade.
    Wu K; DuPré E; Kim H; Tin-U CK; Bissonnette RP; Lamph WW; Brown PH
    Breast Cancer Res Treat; 2006 Mar; 96(2):147-57. PubMed ID: 16273314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abrogation of transforming growth factor-alpha/epidermal growth factor receptor autocrine signaling by an RXR-selective retinoid (LGD1069, Targretin) in head and neck cancer cell lines.
    Song JI; Lango MN; Hwang JD; Drenning SD; Zeng Q; Lamph WW; Grandis JR
    Cancer Res; 2001 Aug; 61(15):5919-25. PubMed ID: 11479234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The retinoid X receptor-selective retinoid, LGD1069, down-regulates cyclooxygenase-2 expression in human breast cells through transcription factor crosstalk: implications for molecular-based chemoprevention.
    Kong G; Kim HT; Wu K; DeNardo D; Hilsenbeck SG; Xu XC; Lamph WW; Bissonnette R; Dannenberg AJ; Brown PH
    Cancer Res; 2005 Apr; 65(8):3462-9. PubMed ID: 15833882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-difluoromethylornithine and dehydroepiandrosterone inhibit mammary tumor progression but not mammary or prostate tumor initiation in C3(1)/SV40 T/t-antigen transgenic mice.
    Green JE; Shibata MA; Shibata E; Moon RC; Anver MR; Kelloff G; Lubet R
    Cancer Res; 2001 Oct; 61(20):7449-55. PubMed ID: 11606379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 9-cis-Retinoic acid suppresses mammary tumorigenesis in C3(1)-simian virus 40 T antigen-transgenic mice.
    Wu K; Kim HT; Rodriquez JL; Munoz-Medellin D; Mohsin SK; Hilsenbeck SG; Lamph WW; Gottardis MM; Shirley MA; Kuhn JG; Green JE; Brown PH
    Clin Cancer Res; 2000 Sep; 6(9):3696-704. PubMed ID: 10999763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinoid-induced suppression of squamous cell differentiation in human oral squamous cell carcinoma xenografts (line 1483) in athymic nude mice.
    Shalinsky DR; Bischoff ED; Gregory ML; Gottardis MM; Hayes JS; Lamph WW; Heyman RA; Shirley MA; Cooke TA; Davies PJ
    Cancer Res; 1995 Jul; 55(14):3183-91. PubMed ID: 7541715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific antagonist of retinoid toxicity in mice.
    Standeven AM; Johnson AT; Escobar M; Chandraratna RA
    Toxicol Appl Pharmacol; 1996 May; 138(1):169-75. PubMed ID: 8658506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haploid inactivation of the amplified-in-breast cancer 3 coactivator reduces the inhibitory effect of peroxisome proliferator-activated receptor gamma and retinoid X receptor on cell proliferation and accelerates polyoma middle-T antigen-induced mammary tumorigenesis in mice.
    Zhang H; Kuang SQ; Liao L; Zhou S; Xu J
    Cancer Res; 2004 Oct; 64(19):7169-77. PubMed ID: 15466215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of adipocyte-specific gene expression is correlated with mammary tumor regression by the retinoid X receptor-ligand LGD1069 (targretin).
    Agarwal VR; Bischoff ED; Hermann T; Lamph WW
    Cancer Res; 2000 Nov; 60(21):6033-8. PubMed ID: 11085524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of LGD1069 (Targretin), a retinoid X receptor-selective ligand, for treatment of uterine leiomyoma.
    Gamage SD; Bischoff ED; Burroughs KD; Lamph WW; Gottardis MM; Walker CL; Fuchs-Young R
    J Pharmacol Exp Ther; 2000 Nov; 295(2):677-81. PubMed ID: 11046105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Phase I study of LGD1069 in adults with advanced cancer.
    Rizvi NA; Marshall JL; Dahut W; Ness E; Truglia JA; Loewen G; Gill GM; Ulm EH; Geiser R; Jaunakais D; Hawkins MJ
    Clin Cancer Res; 1999 Jul; 5(7):1658-64. PubMed ID: 10430065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of new retinoids in the prevention of mammary cancers and correlations with short-term biomarkers.
    Grubbs CJ; Lubet RA; Atigadda VR; Christov K; Deshpande AM; Tirmal V; Xia G; Bland KI; Eto I; Brouillette WJ; Muccio DD
    Carcinogenesis; 2006 Jun; 27(6):1232-9. PubMed ID: 16344269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of cytokeratins 8 and 18 in human breast cancer T47D cells is retinoid-specific and retinoic acid receptor-dependent.
    Jing Y; Zhang J; Waxman S; Mira-y-Lopez R
    Differentiation; 1996 May; 60(2):109-17. PubMed ID: 8641545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor specificity of retinoid-induced epidermal hyperplasia: effect of RXR-selective agonists and correlation with topical irritation.
    Thacher SM; Standeven AM; Athanikar J; Kopper S; Castilleja O; Escobar M; Beard RL; Chandraratna RA
    J Pharmacol Exp Ther; 1997 Aug; 282(2):528-34. PubMed ID: 9262312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhaled isotretinoin (13-cis retinoic acid) is an effective lung cancer chemopreventive agent in A/J mice at low doses: a pilot study.
    Dahl AR; Grossi IM; Houchens DP; Scovell LJ; Placke ME; Imondi AR; Stoner GD; De Luca LM; Wang D; Mulshine JL
    Clin Cancer Res; 2000 Aug; 6(8):3015-24. PubMed ID: 10955779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.